Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

To determine how Athletic Trainers' perceive the effectiveness of concussion risk reduction strategies and how their experiences vary in dealing with concussion risk reduction strategies.

This study is testing a new drug called MRTX1719. The main goal is to find the best dose of the drug to use in future studies. The study will also look at what side effects the drug may cause and how often they happen. Researchers will also measure how quickly the drug is absorbed into the bloodstream and how fast the body gets rid of it. Additionally, they will check how well MRTX1719 works against cancer.

The purpose of this study is to see if adding LY3537982 to standard cancer treatments works better than just using the standard treatments alone for people with advanced non-small cell lung cancer (NSCLC) who have not yet been treated.

Are you newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and looking for treatment options? Our study is evaluating new therapies specifically designed for patients with these conditions. If you have not previously tried an anti-cancer therapy for AML/MDS, this study might be for you!

Do you identify as a Black youth? Are you between the ages of 13 and 19? Have you had thoughts on giving up on life? If so, you may be able to participate in a study on a program about preventing suicide for Black youth and their caregivers. We hope this program can make a positive impact on their lives. Compensation is provided.

Do you have a solid tumor that has progressed on other treatments? Do you have at least one measurable tumor? If so, you may be able to take part in a study to improve treatment for advanced solid tumors. We are exploring how safe and effective a combination of drugs is.

In this study, researchers want to find out the highest safe dose of a drug called [212Pb]VMT-α-NET that can be used to treat neuroendocrine tumors.

Do you have a history of breast cancer? Are you done with active breast cancer treatment? Do you live in North Carolina? You may be able to participate in a research study that seeks to understand how different factors have impacted people's emotional well-being during the breast cancer survivorship period. Compensation provided

Have you been diagnosed with Severe Aplastic Anemia (SAA), but don't have a matched sibling donor? If so, you may be able to take part in a study to see if a bone marrow transplant from a donor that is not related can help treat your disease. Compensation provided.